日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer

监测血浆和尿液中肿瘤来源的DNA,以指导肌层浸润性膀胱癌患者的膀胱保留治疗方案

Galsky, Matthew D; Izadmehr, Sudeh; Yu, Menggang; Curtis, Samuel D; Douville, Christopher; Popoli, Maria; Ptak, Janine; Dobbyn, Lisa; Silliman, Natalie; Chan, Kevin G; Dorff, Tanya B; Cetnar, Jeremy P; O'Neil, Brock; D'Souza, Anishka; Mamtani, Ronac; Kyriakopoulos, Christos E; Brody, Rachel; Sadimin, Evita; Mehrazin, Reza; Chowell, Diego; Sfakianos, John; Daneshmand, Siamak; Pal, Sumanta K; Bettegowda, Chetan; Kinzler, Kenneth W; Papadopoulos, Nickolas; Vogelstein, Bert; Wang, Yuxuan

Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216

转移性激素敏感性前列腺癌患者体重指数与总生存期的相关性:SWOG-1216患者个体数据分析

Swami, Umang; Jo, Yeonjung; Narang, Arshit; Plets, Melissa; Hage Chehade, Chadi; Gebrael, Georges; Gupta, Shilpa; Myint, Zin; Tangen, Catherine; Lara, Primo N Jr; Thompson, Ian M Jr; Hussain, Maha H A; Dorff, Tanya B; Lerner, Seth P; Agarwal, Neeraj

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer

Wnt通路基因改变在晚期前列腺癌患者中的临床意义

Broderick, Amanda; Pan, Elizabeth; Li, Jinju; Chu, Alec; Hwang, Clara; Barata, Pedro C; Cackowski, Frank Cameron; Labriola, Matthew; Ghose, Alyssa; Bilen, Mehmet Asim; Kilari, Deepak; Thapa, Bicky; Piero, Michael; Graham, Laura; Tripathi, Abhishek; Garje, Rohan; Koshkin, Vadim S; Hernandez, Erik; Dorff, Tanya B; Schweizer, Michael Thomas; Alva, Ajjai Shivaram; McKay, Rana R; Armstrong, Andrew J

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

将普遍的生殖系基因检测纳入前列腺癌患者的标准治疗方案:时不我待

Shore, Neal; Nielsen, Sarah M; Esplin, Edward D; Antonarakis, Emmanuel S; Barata, Pedro C; Beer, Tomasz M; Beltran, Himisha; Bryce, Alan; Cookson, Michael S; Crawford, E David; Dorff, Tanya B; George, Daniel J; Heath, Elisabeth I; Helfand, Brian T; Hussain, Maha; Mckay, Rana R; Morgans, Alicia K; Morris, Michael J; Paller, Channing J; Ross, Ashley E; Sartor, Oliver; Shen, John; Sieber, Paul; Smith, Matthew R; Wise, David R; Armstrong, Andrew J

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer.

去势抵抗性前列腺癌患者接受恩扎卢胺单药治疗或联合镭-223治疗期间的免疫调节

Zang Peter D, Da Silva Diane M, Liu Zhang-Xu, Kandukuri Shivani, Tsao-Wei Denice, D'Souza Anishka, Kast W Martin, Pal Sumanta K, Kefauver Cheryl, Juanqueira Maribel, Yang Lixin, Quinn David I, Dorff Tanya B

Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer

奥拉帕尼和度伐利尤单抗治疗伴有DNA损伤修复改变和生化复发性前列腺癌的患者

Autio, Karen A; McHugh, Deaglan J; Rathkopf, Dana E; Xiao, Han; Merugu, Swathi; Wong, Phillip; Jan, Mehrin; Dorff, Tanya B; Heath, Elisabeth I; Scher, Howard I

Geriatric Assessment-driven INterventions among Hospitalized older adults with cancer (GAIN-HOSP), a prospective pilot study

针对住院老年癌症患者的基于老年评估的干预措施(GAIN-HOSP):一项前瞻性试点研究

Cabrera Chien, Leana; Sun, Can-Lan; Kim, Heeyoung; Uranga, Carolina; Soto-Perez-de-Celis, Enrique; Burhenn, Peggy; Charles, Kemeberly; Vazquez, Jessica; Roberts, Elsa; Yu, Wai; Kim, Jae Y; Lau, Clayton; Sentovich, Stephen; Dorff, Tanya B; Sedrak, Mina S; Katheria, Vani; Hurria, Arti; Dale, William; Li, Daneng

Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion

晚期尿路上皮癌临床试验的入组标准:现代化和纳入情况评估

Mercier, Benjamin D; Govindarajan, Ameish; Castro, Daniela V; Li, Xiaochen; Philip, Errol J; Feng, Matthew I; Prajapati, Sweta R; Chan, Elyse H; Lee, Kyle O; Sehgal, Ishaan; Patel, Jalen; O'Dell, Anna; Chehrazi-Raffle, Alexander; Ebrahimi, Hedyeh; Rock, Adam; Zengin, Zeynep Busra; Meza, Luis A; Dizman, Nazli; Hsu, JoAnn; Liu, Sandy; Dorff, Tanya B; Pal, Sumanta K; Tripathi, Abhishek

Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

作者更正:吉西他滨联合顺铂和纳武利尤单抗作为保留器官治疗肌层浸润性膀胱癌的方案:一项 II 期试验

Galsky, Matthew D; Daneshmand, Siamak; Izadmehr, Sudeh; Gonzalez-Kozlova, Edgar; Chan, Kevin G; Lewis, Sara; Achkar, Bassam El; Dorff, Tanya B; Cetnar, Jeremy Paul; Neil, Brock O; D'Souza, Anishka; Mamtani, Ronac; Kyriakopoulos, Christos; Jun, Tomi; Gogerly-Moragoda, Mahalya; Brody, Rachel; Xie, Hui; Nie, Kai; Kelly, Geoffrey; Horowitz, Amir; Kinoshita, Yayoi; Ellis, Ethan; Nose, Yohei; Ioannou, Giorgio; Cabal, Rafael; Del Valle, Diane M; Haines, G Kenneth; Wang, Li; Mouw, Kent W; Samstein, Robert M; Mehrazin, Reza; Bhardwaj, Nina; Yu, Menggang; Zhao, Qianqian; Kim-Schulze, Seunghee; Sebra, Robert; Zhu, Jun; Gnjatic, Sacha; Sfakianos, John; Pal, Sumanta K

Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study

Xaluritamig,一种针对转移性去势抵抗性前列腺癌的STEAP1 × CD3 XmAb 2+1免疫疗法:首次人体试验剂量探索结果

Kelly, William K; Danila, Daniel C; Lin, Chia-Chi; Lee, Jae-Lyun; Matsubara, Nobuaki; Ward, Patrick J; Armstrong, Andrew J; Pook, David; Kim, Miso; Dorff, Tanya B; Fischer, Stefanie; Lin, Yung-Chang; Horvath, Lisa G; Sumey, Christopher; Yang, Zhao; Jurida, Gabor; Smith, Kristen M; Connarn, Jamie N; Penny, Hweixian L; Stieglmaier, Julia; Appleman, Leonard J